Stereotactic Radiosurgery Safe for Koos Grade I Vestibular Schwannomas
By Lori Solomon HealthDay Reporter
TUESDAY, Nov. 19, 2024 -- Stereotactic radiosurgery (SRS) is safe and effective for management of Koos grade I vestibular schwannomas (VS) compared with observation, according to a study published online Nov. 6 in Neurosurgery.
Othman Bin-Alamer, M.B.B.S., from the University of Pittsburgh Medical Center, and colleagues evaluated the safety and efficacy of SRS versus observation for Koos grade I VS. The analysis included 142 patients.
During a median 36 months of follow-up, the researchers found that SRS significantly enhanced tumor control versus observation, with a 100 percent control rate at both five and eight years in the SRS group versus 48.6 and 29.5 percent in the observation group, respectively. At five and eight years, preservation of serviceable hearing outcomes between groups showed no significant differences (70.1 percent for SRS versus 53.4 percent for observation at five years). SRS was associated with a lower likelihood of tinnitus (odds ratio, 0.46), vestibular dysfunction (odds ratio, 0.17), and overall cranial nerve dysfunction (odds ratio, 0.49) at last follow-up.
"These findings support the safety and efficacy of SRS as a primary care approach for this patient population," the authors write. "Further prospective randomized studies are needed to validate these observations and delineate the superiority of SRS in this patient population."
Several authors disclosed ties to the biotechnology industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
Presurgical Immunotherapy Offers Long-Term Benefit in Melanoma
FRIDAY, July 18, 2025 -- Neoadjuvant systemic treatment (NST) followed by adjuvant treatment with nivolumab and relatlimab offers long-term benefit in adults with stage III/IV...
Velar Adhesion Reduces Cleft Width Prior to Palatoplasty in Cleft Lip
TUESDAY, July 15, 2025 -- For patients with unilateral cleft lip and palate (UCLP), velar adhesion (VA) reduces cleft width prior to palatoplasty and is associated with a lower...
Wearable-Derived Biorhythms Predict Complications After Appendectomy
MONDAY, July 14, 2025 -- Wearable-derived biorhythms can predict postoperative complications in children undergoing appendectomy, according to a study published online July 9 in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.